ATF1 and sarcoma: Cheng and colleagues reported gene amplification of the chromosome region containing ATF1 could be a predictive biomarker for high sensitivity of sarcoma cell lines to several chemotherapeutics including alkylating agents and nucleoside analogues, but not bleomycin (47).